氢溴酸羟苯丙胺，CAS 登记号 306-21-8，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 氢溴酸羟苯丙胺 的 CAS 号：306-21-8，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
hydroxyamfetamine hydrobromide · CAS 306-21-8 · C9H14BrNO. UNII 59IG47SZ0E.
| CAS Registry Number | 306-21-8 |
|---|---|
| PubChem CID | 9377 |
| Molecular formula | C9H14BrNO |
| IUPAC name | 4-(2-aminopropyl)phenol;hydrobromide |
| UNII (FDA) | 59IG47SZ0E |
| Molecular Weight | 232.12 |
|---|---|
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| Exact Mass | 231.02588 |
| Monoisotopic Mass | 231.02588 |
| Topological Polar Surface Area | 46.3 |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 108 |
| Reported hazard statements | H300, H330 (33.3%), H302 (66.7%), H315 (66.7%), H319 (66.7%), H335 (66.7%), H336 (33.3%), H373 (33.3%) |
|---|
H300+H330 (33.3%): Fatal if swallowed or if inhaled [Danger Acute toxicity, oral; acute toxicity, inhalation]
H300 (33.3%): Fatal if swallowed [Danger Acute toxicity, oral]
HYDROXYAMPHETAMINE HYDROBROMIDE; 306-21-8; Paredrine; Predrolon; Hydroxyamfetamine hbr; hydroxyamfetamine hydrobromide; Hydroxyamphetamine hbr; DTXSID0045961; Phenol, 4-(2-aminopropyl)-, hydrobromide; NSC-61065; 59IG47SZ0E; Phenol, 4-(2-aminopropyl)-, hbr; beta-(p-Hydroxyphenyl)isopropylamine hydrobromide; DTXCID8025961; NSC61065; Hydroxyamphetamine hydrobromide (USP)
CAS 306-21-8; molecular formula C9H14BrNO; molecular weight — g/mol.
HYDROXYAMPHETAMINE HYDROBROMIDE, 306-21-8, Paredrine, Predrolon, Hydroxyamfetamine hbr, hydroxyamfetamine hydrobromide.
Hazard statements reported: H300, H330, H302, H315, H319.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.